Among those not currently using GLP-1 medications, 4% of respondents said they have concrete plans to begin using GLP-1 in the next 12 months, while an additional 13% said they are considering starting the medication
If you have access to a kitchen, have a plan to stock it with GLP-1 friendly options to prepare your own meals and snacks
Nanoparticles decorated with ligands for cardiomyocyte-specific receptors enable passive targeting (e.g., the EPR effect), active targeting, and intelligent drug release in response to the pathological microenvironment (e.g., pH and enzymes), ensuring drug enrichment and localized release at the cardiac site [255, 256]
[DOI] [PubMed] [Google Scholar] [11].Butterfield DA, Bader Lange ML, Sultana R
Trachtenberg, J
Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes